Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2001, p. 224-234, Vol. 21, No. 1
Laboratory of Molecular Genetics of
Hemopoietic Stem Cells, Clinical Research Institute of Montréal,
Montréal, Québec H2W 1R7,1
Department of Medicine, Université de Montréal,
Montréal, Québec H3C 3J7,3
and Division of Hematology, Maisonneuve-Rosemont Hospital,
Université de Montréal, Montréal, Québec
H1T 2M2,4 Canada, and Molecular Genetics
Unit, DIBIT, Universita Vita-Salute San Raffaele, 20132 Milan,
Italy2
Received 21 July 2000/Returned for modification 13 September
2000/Accepted 12 October 2000
Complex genetic and biochemical interactions between HOX proteins
and members of the TALE (i.e., PBX and MEIS) family have been
identified in embryonic development, and some of these interactions also appear to be important for leukemic transformation. We have previously shown that HOXA9 collaborates with
MEIS1 in the induction of acute myeloid leukemia (AML). In
this report, we demonstrate that HOXB3, which is highly
divergent from HOXA9, also genetically interacts with
MEIS1, but not with PBX1, in generating AML. In addition, we show that the HOXA9 and HOXB3
genes play key roles in establishing all the main characteristics of
the leukemias, while MEIS1 functions only to accelerate the
onset of the leukemic transformation. Contrasting the reported
functional similarities between PREP1 and MEIS1, such as PBX nuclear
retention, we also show that PREP1 overexpression is
incapable of accelerating the HOXA9-induced AML, suggesting
that MEIS1 function in transformation must entail more than PBX nuclear
localization. Collectively, these data demonstrate that
MEIS1 is a common leukemic collaborator with two
structurally and functionally divergent HOX genes and that,
in this collaboration, the HOX gene defines the identity of
the leukemia.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.1.224-234.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Defining Roles for HOX and MEIS1 Genes in
Induction of Acute Myeloid Leukemia
*
Corresponding author. Mailing address: Institut de
Recherches Cliniques de Montréal, 110 Pine Ave. West, Montreal,
Quebec, Canada H2W 1R7. Phone: (514) 987-5797. Fax: (514) 987-5718. E-mail: sauvagg{at}ircm.qc.ca.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|